Anna Grenda

Anna Grenda is an Assistant Professor at the Laboratory for Immunology and Genetics, Faculty of Medicine, Medical University of Lublin, where she conducts advanced research at the intersection of immunology, genetics, and oncology. Her work contributes significantly to understanding molecular mechanisms in cancer, particularly non-small cell lung cancer, and exploring novel immunotherapeutic strategies.

Her research interests focus on medical sciences, with specialized expertise in immunology and genetics. Key areas include B cell biology, tumor microenvironment, gene expression profiling, microRNA regulation, biomarker discovery, and molecular targeted therapies. These interests are reflected in her extensive publication record and active research in translational medicine.

The available data shows a robust scholarly output, though specific article titles were not provided. However, the thematic concentration across her work indicates a consistent trajectory in cancer immunology, particularly in identifying prognostic biomarkers and therapeutic targets in solid tumors, leveraging genomic and immunological approaches.

While no specific awards are listed, her recognition through a DSc degree, a patent, and promotion of a doctoral thesis underscores her academic standing. She has contributed to the scientific community through over 90 publications and active mentorship.

Anna Grenda is actively involved in research leadership within her laboratory, guiding investigations into immune-genetic interactions in cancer. Her work likely involves collaboration across multidisciplinary teams, given the complexity of modern biomedical research and the multi-center nature of some of her publications.